Our mission to understand human genetic disease is being pursued on several fronts. The Coriell Personalized Medicine Collaborative® (CPMC®) research study is seeking to understand the usefulness of genetic information in clinical care. We are also building upon our history in cell biology by playing an important role in induced pluripotent stem cell (iPSC) research. And, Coriell’s Biobank manages the world’s most diverse collection of cell lines, DNA, and other biomaterials gathered and distributed for use by the international biomedical research community. In fact, in 1960 Coriell was one of the first two official cell banks recognized by the National Institute of Health.